The Evolving Evidence-Based and Guideline-Supported Role for Nanoliposomal Topoisomerase Inhibitors in Metastatic Pancreatic Adenocarcinoma

The Evolving Evidence-Based and Guideline-Supported Role for Nanoliposomal Topoisomerase Inhibitors in Metastatic Pancreatic Adenocarcinoma


Published

October 31, 2017

Created by

CMEducation Resources symposium

Related Presenters

Alok A. Khorana, MD

Alok A. Khorana, MD

Professor
Cleveland Clinic Lerner College of Medicine
Cleveland, Ohio